Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors.
Wang C, Tang H, Geng A, Dai B, Zhang H, Sun X, Chen Y, Qiao Z, Zhu H, Yang J, Chen J, He Q, Qin N, Xie J, Tan R, Wan X, Gao S, Jiang Y, Sun FL, Mao Z.
Wang C, et al. Among authors: chen j, chen y.
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26356-26365. doi: 10.1073/pnas.2002917117. Epub 2020 Oct 5.
Proc Natl Acad Sci U S A. 2020.
PMID: 33020270
Free PMC article.